During the past decade, Sapporo Medical University Hospital conducted 57 clinical trials. In the 10-year time frame, 57 clinical trials started and 22 clinical trials were completed, i.e. on average, 38.6% percent of trials that started reached the finish line to date. In the past 5 years, 33 clinical trials started and 18 clinical trials were completed. i.e. 54.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sapporo Medical University Hospital" #1 sponsor was "Boehringer Ingelheim" with 5 trials, followed by "Shire" with 5 trials sponsored, "Janssen Research & Development, LLC" with 4 trials sponsored, "Actelion" with 3 trials sponsored and "Eli Lilly and Company" with 3 trials sponsored. Other sponsors include 44 different institutions and companies that sponsored additional 36 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sapporo Medical University Hospital" #1 collaborator was "Ministry of Health, Labour and Welfare, Japan" with 3 trials as a collaborator, "Chugai Pharmaceutical" with 2 trials as a collaborator, "Eisai Inc." with 2 trials as a collaborator, "Japan Lung Cancer Society" with 2 trials as a collaborator and "Merck Sharp & Dohme LLC" with 2 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Sapporo Medical University Hospital" are "Crohn's Disease" (6 trials), "Ulcerative Colitis" (5 trials), "Carcinoma, Renal Cell" (3 trials), "Lung Diseases, Interstitial" (3 trials) and "Colitis, Ulcerative" (2 trials). Many other conditions were trialed in "Sapporo Medical University Hospital" in a lesser frequency.

Most popular intervention types in "Sapporo Medical University Hospital" are "Drug" (60 trials), "Other" (10 trials), "Biological" (5 trials), "Device" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (25 trials), "Nintedanib" (4 trials), "Ontamalimab" (4 trials), "Pembrolizumab" (3 trials) and "Ustekinumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Sapporo Medical University Hospital" are 61 trials for "All" genders, 4 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Sapporo Medical University Hospital". undefined are not yet recruiting, 13 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in Sapporo Medical University Hospital, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Sapporo Medical University Hospital, 2 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 44 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".